NEUROTHERANOSTICS, INC.

Biotech · Private

B27-HYD, an intravenous peptide therapeutic for traumatic brain injury

Grants
$834K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
6
0 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Calpastatin Peptide-based Calpain Inhibitor as a Traumatic Brain Injury Therapeutic$564,575
Federal grantDepartment of Health and Human Services · Phase I · Calpastatin Peptide-based Calpain Inhibitor as a Traumatic Brain Injury Therapeutic$269,618
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2104Legacy Lyfe Holdings, LLC—$5.3M
2105Douleur Therapeutics Inc——
2106YEWSAVIN, INC.——
2107NEUROTHERANOSTICS, INC.——
2108Twenty-Two Desserts, Inc.—$1.4M
2109AVIVA BIOSCIENCES CORP—$500K
2110BE Biopharma——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 6
  • Methods, Systems And Compositions For Traumatic Brain Injury And Associated Neurodegenerative Disease Immune Response Diagnosticsapplication
  • Methods, Systems And Compositions For Traumatic Brain Injury And Associated Neurodegenerative Disease Immune Response Diagnosticsapplication
  • Multiple Layer Article With Interactive Reinforcements Linear Ribbon Fiber Reinforcement For Composite Formsapplication
  • Methods, Systems And Compositions For Whole Brain Proteome-based Traumatic Brain Injury (tbi) And Associated Neurodegenerative Disease Immune Response Diagnosticsapplication
  • Methods, Systems And Compositions For Traumatic Brain Injury And Associated Neurodegenerative Disease Immune Response Diagnosticsapplication
  • Compositions And Methods For Treating Traumatic Brain Injuryapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.